Literature DB >> 28607307

Helpline facility to assist reporting of adverse drug reactions in India.

Vivekanandan Kalaiselvan1, Prabhakar Mishra1, Gyanendra N Singh1.   

Abstract

Year:  2014        PMID： 28607307     DOI： 10.4103/2224-3151.206737

Source DB:  PubMed          Journal:  WHO South East Asia J Public Health        ISSN： 2224-3151


× No keyword cloud information.
  7 in total

1.  Reporting of adverse drug reactions due to cardiovascular drugs in India: A national duty.

Authors:  Vivekanandan Kalaiselvan; Ismeet Kaur; Vipin Kumar; Gyanendra N Singh
Journal:  Indian Heart J       Date:  2015-09-11

2.  Medicine Safety Monitoring in Pediatric Population in India.

Authors:  Ismeet Kaur; Vivekanandan Kalaiselvan; Gyanendra N Singh
Journal:  Indian J Pediatr       Date:  2015-12-04       Impact factor: 1.967

3.  Pharmacovigilance in drugs used in the treatment of drug dependence.

Authors:  Anusha Thota; Prasad Thota; Vivekanandan Kalaiselvan; Siddharth Sarkar; Gyanendra Nath Singh
Journal:  Indian J Psychiatry       Date:  2017 Jul-Sep       Impact factor: 1.759

4.  Safety monitoring of local anaesthetic drugs from the perspective of Pharmacovigilance Programme of India.

Authors:  Pramod Kumar; Ismeet Kaur; Vivekanandan Kalaiselvan; Abhishank Singh
Journal:  Indian J Anaesth       Date:  2017-07

5.  Implementation of adverse event reporting for medical devices, India.

Authors:  Shatrunajay Shukla; Madhur Gupta; Sabitri Pandit; Milu Thomson; Abhimanyu Shivhare; Vivekanandan Kalaiselvan; Gyanendra Nath Singh
Journal:  Bull World Health Organ       Date:  2019-11-18       Impact factor: 9.408

Review 6.  A global comparison of implementation and effectiveness of materiovigilance program: overview of regulations.

Authors:  Deeksha Joshi; Ishita Sharma; Saurabh Gupta; Thakur Gurjeet Singh; Sonia Dhiman; Abhimanyu Prashar; Monica Gulati; Bimlesh Kumar; Sukriti Vishwas; Dinesh Kumar Chellappan; Gaurav Gupta; Niraj Kumar Jha; Piyush Kumar Gupta; Poonam Negi; Kamal Dua; Sachin Kumar Singh
Journal:  Environ Sci Pollut Res Int       Date:  2021-09-13       Impact factor: 4.223

7.  Public-private partnership (3Ps) in ensuring safe use of medicines: An Indian experience.

Authors:  Vivekanandan Kalaiselvan; Shatrunajay Shukla; Shubhang Arora; Tarani Prakash Shrivastava; Rajeev Singh Raghuvanshi
Journal:  Front Public Health       Date:  2022-08-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.